Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-01-19

Clinical Trial Update: Study Comparing Olanzapine With Haloperidol for the Relief of Nausea and Vomiting in Patients With Advanced Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing olanzapine with haloperidol for relief of nausea and vomiting in patients with advanced cancer. The study status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HALOPERIDOL (HALOPERIDOL LACTATE)
  • olanzapine (olanzapine)

Snippet

Sponsor: Alberta Health services | Conditions: Nausea, Neoplasms | Phase 3 | Status: TERMINATED